Torrent Pharmaceuticals Limited has submitted a regulatory filing to both BSE Limited and National Stock Exchange of India Ltd. regarding an upcoming board meeting.
The company intimates that a meeting of the Board of Directors is scheduled to be held on Thursday, 30th July 2026. The primary agenda of this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026. The financial results will be accompanied by a limited review report.
This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed entities to intimate stock exchanges about board meetings where financial results will be considered.
The letter was signed by CHINTAN M. TRIVEDI, Company Secretary, on 16th July 2026 at 14:45:45 IST.